cvac patients posting trial progress, page-16

Hello Digster

Southoz said
"Mainly because it seemed clear that there would not be an update for Overall Survival (OS) from Can-003 until the end of the year. "

I have not been able to listen to the presentation you both reference and was wondering if you got the same impression regarding no OS update for CAN-003 is to be presented by Dr Gray at the ASCO meeting the end of next month.

This seems to contradict the news from the company that they posted 28/3/2014
"Dr. Gray will present the final progression-free survival data (PFS) and an update on overall survival (OS) from the Randomized, Open-Label Phase IIb Trial of Maintenance Therapy with a MUC1 Dendritic Cell Vaccine (CVacTM) for Epithelial Ovarian Cancer Patients in First or Second Remission (Prima protocol CAN-003)."
Thanks in advance.